Clinical significance of hormonal receptor status of malignant ovarian tumors
Tkalia, I G, Vorobyova, L I, Svintsitsky, V S, Nespryadko, S V, Goncharuk, I V, Lukyanova, N Y, Chekhun, V F
Published in Experimental oncology (01.06.2014)
Get more information
Published in Experimental oncology (01.06.2014)
Journal Article
The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
Tkalia, I G, Vorobyova, L I, Grabovoy, A N, Svintsitsky, V S, Tarasova, T O
Published in Experimental oncology (01.03.2015)
Published in Experimental oncology (01.03.2015)
Get more information
Journal Article
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
Tkalia, I G, Vorobyova, L I, Grabovoy, A N, Svintsitsky, V S, Tarasova, T O, Lukyanova, N Y, Todor, I N, Chekhun, V F
Published in Experimental oncology (01.09.2014)
Get more information
Published in Experimental oncology (01.09.2014)
Journal Article